KR910700347A - 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 - Google Patents
프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 Download PDFInfo
- Publication number
- KR910700347A KR910700347A KR1019900701934A KR900701934A KR910700347A KR 910700347 A KR910700347 A KR 910700347A KR 1019900701934 A KR1019900701934 A KR 1019900701934A KR 900701934 A KR900701934 A KR 900701934A KR 910700347 A KR910700347 A KR 910700347A
- Authority
- KR
- South Korea
- Prior art keywords
- nucleotide sequence
- gene
- recombinant
- virus
- abipoxvirus
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title claims 5
- 239000002773 nucleotide Substances 0.000 claims 15
- 125000003729 nucleotide group Chemical group 0.000 claims 15
- 108090000623 proteins and genes Proteins 0.000 claims 14
- 241000700605 Viruses Species 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 3
- 241000711404 Avian avulavirus 1 Species 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 241000700663 Avipoxvirus Species 0.000 claims 1
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000700662 Fowlpox virus Species 0.000 claims 1
- 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1,2,3도는 본 발명에 따라 프로모터 활성을 갖는 단편 14-6, 49-22, 41-3 및 37-1의 뉴클레오티드 서열을 나타낸다.
Claims (12)
- 프로모터 활성을 갖는 제1,2,3 또는 4도에 나타낸 뉴클레오티드 서열의 일부 또는 전부를 함유하는 뉴클레오티드 서열.
- 제1항에 있어서, 뉴클레오티드 서열이 제4도에 나타낸 뉴클레오티드 서열중 404~515 뉴클레오티드의 일부 또는 전부를 함유하는 것인 뉴클레오티드 서열.
- 제2항에 있어서, 뉴클레오티드 서열이 제4도에 나타낸 뉴클레오티드 서열중 489~505 뉴클레오티드의 일부 또는 전부를 함유하는 것인 뉴클레오티드 서열.
- 제1항 내지 3항중 어느 한 항의 뉴클레오티드 서열, 및 상기 뉴클레오티드 서열 지배하에 있는, 폴리펩티드를 코팅하는 외인성 유전자를 함유하는 키메라9chimera) 유전자.
- 제4항에 있어서, 상기 외인성 유전자가 뉴카슬병(New-castle disease) 비루스 항원을 코딩하는 유전자인 키메라 유전자.
- 제5항에 있어서, 상기 뉴카슬병 비루스 항원이 헤마글루미닌 뉴라미니다제(hemagglutinin neuraminidase)인 키메라 유전자.
- 제4항 내지 6항중 어느 한 항에 따른 키메라 유전자를 함유하며 에스케리키아콜리(Escherichia coli)내에서 증식할 수 있는 플라스미드.
- 제7항에 있어서, 상기 키메라 유전자가 아비폭스비루스(Avipoxvirus)의 증식에 비-필수적인 게놈 영역에서 유래된 뉴클레오티드 서열내에 삽입된 플라스미드.
- 아비폭스비루스의 증식에 비-필수적인 게놈 영역내에 삽입된, 제4항 내지 6항중 어느 한 항에 따른 키메라 유전자를 함유하는 재조합 아비폭스비루스.
- 제9항에 있어서, 상기 아비폭스비루스가 파울폭스비루스(fowlpoxvirus)인 재조합 아비폭스비루스.
- 프로모터 지배하에 있지 않은 마커 유전자를 함유하는 플라스미드의 마키 유전자의 상류에 비루스-유래 DNA 단면을 삽입하고, 상기 플라스미드를 사용하여 재조합 비루스를 제작하고, 재조합 비루스로 마커 유전자-삭제 세포를 감염시키고, 마키 유전자가 발현되는 세포를 선택하고, 및 삽입된 DNA 단면의 뉴클레오티드 서열을 분석함을 특징으로 하는, 프로모터 활성을 갖는 뉴클레오티드 서열의 선택방법.
- 제10항에 있어서, 상기 마커 유전자가 1acz 유전자인 프로모터 활성을 갖는 뉴클레오티드 서열의 선택방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33560588 | 1988-12-29 | ||
JP63-335605 | 1988-12-29 | ||
JP1-76025 | 1989-03-28 | ||
JP7602589 | 1989-03-28 | ||
PCT/JP1989/001330 WO1990007581A1 (fr) | 1988-12-29 | 1989-12-28 | Promoteur, plasmide le contenant, et avipoxvirus de recombinaison |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910700347A true KR910700347A (ko) | 1991-03-14 |
KR940001265B1 KR940001265B1 (ko) | 1994-02-18 |
Family
ID=26417177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900701934A KR940001265B1 (ko) | 1988-12-29 | 1989-12-28 | 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0419666A4 (ko) |
KR (1) | KR940001265B1 (ko) |
AU (1) | AU623476B2 (ko) |
WO (1) | WO1990007581A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0353851B1 (en) * | 1988-06-24 | 1994-01-19 | Btg International Limited | Fowlpox virus non-essential regions |
JP2781605B2 (ja) * | 1989-06-22 | 1998-07-30 | 日本ゼオン株式会社 | 組み換えアビポックスウイルス |
KR930701588A (ko) * | 1990-07-02 | 1993-06-12 | 스튜어트 알. 슈터 | 재조합 구두 바이러스 백신 |
BE1004877A3 (fr) * | 1991-05-27 | 1993-02-16 | Solvay | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61170393A (ja) * | 1985-01-21 | 1986-08-01 | Nippon Zeon Co Ltd | 組換え体ベクタ−及びその製造法 |
JPS61271990A (ja) * | 1985-05-27 | 1986-12-02 | Agency Of Ind Science & Technol | 改造ジヒドロ葉酸還元酵素遺伝子を含む特定dna配列 |
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
DE3853088T2 (de) * | 1987-03-27 | 1995-10-19 | Nippon Zeon Co | Rekombinantes Avipoxvirus. |
CA1340203C (en) * | 1987-09-16 | 1998-12-15 | Noboru Yanagida | Recombinant apivoxvirus |
EP0353851B1 (en) * | 1988-06-24 | 1994-01-19 | Btg International Limited | Fowlpox virus non-essential regions |
CA2001001A1 (en) * | 1988-10-21 | 1990-04-21 | Matthew M. Binns | Fowlpox virus promoter |
-
1989
- 1989-12-28 KR KR1019900701934A patent/KR940001265B1/ko not_active IP Right Cessation
- 1989-12-28 AU AU48240/90A patent/AU623476B2/en not_active Ceased
- 1989-12-28 WO PCT/JP1989/001330 patent/WO1990007581A1/ja not_active Application Discontinuation
- 1989-12-28 EP EP19900901019 patent/EP0419666A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0419666A1 (en) | 1991-04-03 |
WO1990007581A1 (fr) | 1990-07-12 |
EP0419666A4 (en) | 1991-05-15 |
KR940001265B1 (ko) | 1994-02-18 |
AU623476B2 (en) | 1992-05-14 |
AU4824090A (en) | 1990-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Britton et al. | Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus | |
ATE142700T1 (de) | Genetische manipulationen mit von rna-viren abgeleiteten sequenzen enthaltendem rekombinantem dna | |
EP0414689A4 (en) | Pox virus vectors | |
MX9700817A (es) | Secuencia viral de nucleotidos de "vr-2332" y metodos de uso. | |
ES2173867T3 (es) | Uso de nucleotidos externos a la muestra en clonacion genetica. | |
NL300300I1 (nl) | Expressiesystemen voor recombinante RNA-virussen met een negatieve styreng en vaccins. | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
WO2000003030A3 (en) | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species | |
DE69131903T2 (de) | Klonierung hühner-anaemia-virus-dna | |
KR910700347A (ko) | 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 | |
DK384185D0 (da) | Ekspressionsvektorer | |
DK0651806T3 (da) | Vacciner imod katteimmundeficiensvirus (FIV) | |
ES2061850T3 (es) | Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna. | |
KR910001061A (ko) | 재조합 아비폭스비루스 | |
US5332676A (en) | Avipox virus promoter | |
McCoy et al. | Nucleotide and amino acid sequence analysis of the 100K protein of a serotype 3 porcine adenovirus | |
Smirnov et al. | Synthesis and expression of the DNA fragment coding for antigenic determinant of the protein of hepatitis virus B surface antigen. | |
KR950005988A (ko) | 곤충세포를 이용한 인간 적혈구 성장촉진인자의 제조 | |
KR950003446A (ko) | 돌연변이체 aox2 프로모터, 이를 보유한 벡터, 형질 전환체, 및 이종 단백질의 제조방법 | |
Boyle et al. | Pox virus vaccine | |
KR960014344A (ko) | 담배 모자이크 바이러스 토마토종(TMV-t)의 외피유전자 | |
KR950005840A (ko) | 씨(C)형 간염바이러스의 2비 프로테아제(2B protease) 및 그의 제조방법 | |
KR830010193A (ko) | 바실러스 클로닝 매개체, 재결합 dna분자 그것들과 함께 변형된 간균 숙주 그리고 이종(異知) dna배열의 표현 방법과 그것으로 이루어진 폴리펩타이드의 생성방법 | |
KR950005994A (ko) | 곤충세포를 이용한 씨(C)형 간염바이러스의 핵(Core22) 단백질의 제조 | |
KR930000127A (ko) | 비(非)a 비(非)b형 간염 진단방법 및 백신 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |